Somewhere right now, a mother is draining her retirement account trying to figure out why her child is in pain.
That is the market.
I know because I’ve lived adjacent to it for years.
In my twenties, I participated in clinical genetic research. Not the glossy influencer version of “genetic testing.” Real testing. The kind where licensed genetic counselors walk you through your results line by line, explain your Variant of Uncertain Significance, discuss limitations, talk about next steps, and make sure you understand what the data can — and cannot — actually tell you.
I later worked alongside rare disease organizations like Global Genes and genetic biotech companies. I’ve sat with mothers who haven’t slept through the night in years because they’re terrified they’ll miss the moment their child stops breathing. I’ve met patients so desperate for an answer they would have signed anything, paid anything, mailed blood to anyone who promised they might finally explain the suffering.
And now there are companies building entire businesses around that desperation.
They market directly to chronically ill people using the language of diagnosis and discovery.
But instead of offering clinically validated answers, many sell glorified trait reports.
They can tell you whether cilantro tastes like soap.
Whether you’re likely to sneeze in sunlight.
Whether you metabolize caffeine quickly.
What they cannot do is diagnose complex connective tissue disorders like Ehlers-Danlos syndrome.
So what happens?
A desperate patient pays thousands of dollars hoping for medical clarity.
And what do they receive?
A raw data dump.
No clinical interpretation.
No diagnostic confirmation.
No meaningful pathway to care.
No doctor willing to treat the printout as actionable medicine.
Just enough scientific language to sound legitimate.
Just enough hope to keep the credit card moving.
And the cruelest part is: the customers are often too desperate to know the difference.
Because when your body is collapsing…
when your child is suffering…
when every specialist shrugs…
you stop thinking like a consumer.
You start thinking like someone trying to survive.
And that is the exact psychological state these companies market to.
So here’s the question I cannot stop thinking about:
If your child was screaming in pain every night…
if you had spent ten years being ignored by doctors…
if you genuinely believed there was even a 1% chance a test could save them…
How much money could someone extract from you before it became immoral?
So who can you trust?
None of this is meant to discourage people from pursuing legitimate genetic testing. Clinically validated genetic testing can be life-changing when it is ordered appropriately, interpreted responsibly, and connected to real medical care. Companies like GeneDx, Invitae, and Myriad Genetics built their reputations within clinical medicine — not predatory marketing ecosystems. Their testing is typically ordered through physicians, specialists, or genetic counselors and is designed to answer specific medical questions using validated methodologies and established diagnostic criteria. Most importantly, the results are meant to exist within a healthcare framework: interpreted by professionals, weighed against symptoms and family history, and used to guide actual next steps in care.
That distinction matters more than most patients realize. Ethical genetic testing companies understand that raw DNA data without context can create panic, confusion, false reassurance, or years of diagnostic detours. A Variant of Uncertain Significance is not a diagnosis. A predisposition is not a certainty. And complex conditions like Ehlers-Danlos syndrome often cannot be conclusively diagnosed through consumer-facing genetic sequencing alone, especially for hypermobile subtypes where no definitive genetic marker currently exists.
Reputable companies tend to be far more conservative in their claims precisely because real genetics is nuanced, heavily regulated, and medically complicated. If a company’s marketing sounds too emotionally persuasive, too certain, or too eager to position itself as the answer traditional medicine “doesn’t want you to have,” that should immediately raise questions.
Think your company should be on the list of trusted companies for patients? Reach out at Ilanawrites@gmail.com.